Lauren S Maeda, MD
Hematology/Oncology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maeda’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A100890 · Current
Licensed to practise in California · since 2007 · expires 2028-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$132,903
Medicare paid this office $132,903 for 289 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $53,202 | $106 |
| Long return visit (40+ min) | 82 | $24,426 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,066 | $155 |
| Long return visit (40+ min) | 31 | $10,401 | $168 |
| Hospital discharge day management, more than 30 minutes | 86 | $10,149 | $105 |
See all 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $53,202 | $106 |
| Long return visit (40+ min) | 82 | $24,426 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,066 | $155 |
| Long return visit (40+ min) | 31 | $10,401 | $168 |
| Hospital discharge day management, more than 30 minutes | 86 | $10,149 | $105 |
| Return visit (30+ min) | 60 | $6,454 | $78 |
| Return visit (30+ min) | 35 | $5,921 | $116 |
| New patient visit (60+ min) | 27 | $4,314 | $160 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 98 | $2,668 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 50 | $1,273 | $15 |
Who their Medicare patients are
289 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 11% · Women 49% · Also on Medicaid 24% · Health risk score 2.32. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 73% · Coronary heart disease 32% · Chronic kidney disease 31% · Diabetes 30% · Atrial fibrillation 29% · Cancer 25% · Heart failure 22% · Depression 18% · Dementia 15% · COPD 14% · Stroke 11%.
The office billed $492,107, Medicare allowed $170,309 and paid $132,903; for 1,391 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 289 | 1,391 | 74 | 2.32 | $492,107 | $132,903 |
| 2023 | 284 | 1,025 | 74 | 2.23 | $420,485 | $116,295 |
| 2022 | 227 | 890 | 73 | 2.41 | $365,532 | $92,321 |
| 2021 | 218 | 862 | 74 | 2.04 | $356,087 | $91,187 |
| 2020 | 241 | 985 | 71 | 2.23 | $382,165 | $98,775 |
| 2019 | 179 | 648 | 72 | 2.12 | $184,772 | $64,119 |
| 2018 | 181 | 745 | 72 | 2.35 | $198,963 | $70,826 |
| 2017 | 176 | 724 | 71 | 2.08 | $245,694 | $71,893 |
| 2016 | 152 | 661 | 71 | 2.25 | $224,254 | $64,941 |
| 2015 | 102 | 393 | 71 | 1.99 | $135,397 | $40,420 |
| 2014 | 127 | 515 | 72 | 2.20 | $177,864 | $52,324 |
| 2013 | 147 | 626 | 71 | 2.21 | $212,349 | $60,984 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $48,817 | $110 |
| Long return visit (40+ min) | 91 | $32,870 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,355 | $160 |
| Hospital discharge day management, more than 30 minutes | 68 | $8,247 | $107 |
| Return visit (30+ min) | 82 | $7,649 | $76 |
| New patient visit (60+ min) | 36 | $5,408 | $150 |
| Short return visit (20+ min) | 26 | $1,321 | $47 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $35,546 | $94 |
| Long return visit (40+ min) | 54 | $21,992 | $129 |
| Return visit (30+ min) | 76 | $10,519 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $10,373 | $182 |
| Hospital discharge day management, more than 30 minutes | 64 | $6,618 | $97 |
| New patient visit (60+ min) | 27 | $4,402 | $163 |
| Short return visit (20+ min) | 37 | $2,116 | $52 |
2021: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $29,330 | $96 |
| Long return visit (40+ min) | 55 | $21,520 | $128 |
| Return visit (30+ min) | 84 | $12,231 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $10,362 | $185 |
| Hospital discharge day management, more than 30 minutes | 61 | $7,104 | $100 |
| New patient visit (60+ min) | 35 | $5,946 | $170 |
| Short return visit (20+ min) | 44 | $2,647 | $47 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $44,045 | $97 |
| Long return visit (40+ min) | 52 | $14,670 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $14,322 | $188 |
| Hospital discharge day management, more than 30 minutes | 84 | $9,971 | $102 |
| Return visit (30+ min) | 56 | $6,279 | $65 |
| New patient visit (60+ min) | 34 | $5,214 | $153 |
| Short return visit (20+ min) | 36 | $2,199 | $42 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $23,865 | $94 |
| Long return visit (40+ min) | 46 | $11,308 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $9,911 | $184 |
| Return visit (30+ min) | 52 | $5,957 | $71 |
| Hospital discharge day management, more than 30 minutes | 47 | $5,850 | $99 |
| New patient visit (60+ min) | 31 | $4,721 | $152 |
| Short return visit (20+ min) | 36 | $2,229 | $45 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $25,515 | $93 |
| Long return visit (40+ min) | 42 | $15,722 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,028 | $181 |
| Return visit (30+ min) | 60 | $6,774 | $67 |
| Hospital discharge day management, more than 30 minutes | 49 | $5,333 | $99 |
| New patient visit (60+ min) | 35 | $4,981 | $142 |
| Short return visit (20+ min) | 38 | $1,929 | $40 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $27,098 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $11,965 | $181 |
| Long return visit (40+ min) | 31 | $11,557 | $100 |
| Hospital discharge day management, more than 30 minutes | 50 | $6,888 | $97 |
| New patient visit (60+ min) | 44 | $6,614 | $150 |
| Return visit (30+ min) | 37 | $4,366 | $69 |
| Short return visit (20+ min) | 32 | $2,191 | $45 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $30,427 | $92 |
| Long return visit (40+ min) | 47 | $12,446 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $6,309 | $180 |
| New patient visit (60+ min) | 38 | $5,429 | $143 |
| Hospital discharge day management, more than 30 minutes | 49 | $5,348 | $97 |
| Return visit (30+ min) | 33 | $3,782 | $68 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $17,327 | $93 |
| Long return visit (40+ min) | 41 | $8,584 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $5,257 | $181 |
| Hospital discharge day management, more than 30 minutes | 32 | $3,523 | $98 |
| New patient visit (60+ min) | 18 | $2,700 | $150 |
| Return visit (30+ min) | 21 | $1,755 | $67 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $15,735 | $90 |
| Long return visit (40+ min) | 46 | $14,773 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $8,932 | $175 |
| New patient visit (60+ min) | 40 | $5,863 | $147 |
| Hospital discharge day management, more than 30 minutes | 39 | $4,257 | $93 |
| Return visit (30+ min) | 18 | $1,595 | $61 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $25,142 | $90 |
| Long return visit (40+ min) | 44 | $11,196 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $9,637 | $175 |
| New patient visit (60+ min) | 55 | $7,416 | $135 |
| Hospital discharge day management, 30 minutes or less | 34 | $2,954 | $64 |
| Return visit (30+ min) | 25 | $2,402 | $63 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,508 | $94 |
Medicaid work
$2,551 in 2024
Medicaid paid $2,551 for 58 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 58 | $2,551 |
| 2024 | 58 | 1 | 15 | $2,551 |
| 2023 | 212 | 2 | 15 | $7,147 |
| 2022 | 61 | 2 | 13 | $2,760 |
| 2020 | 131 | 2 | 16 | $5,686 |
| 2018 | 14 | 1 | 12 | $935 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 199 | $6,524 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 13 | $623 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 49 | $1,796 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $964 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 119 | $5,123 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $563 |
2018
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 14 | $935 |
Drugs they prescribed that Part D paid
$194,846
Pharmacies billed $194,846 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 111) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
97 generic and 14 brand-name prescriptions · $194,846 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Acyclovir | 31 | $539 | $17 |
| Ondansetron | 11 | $125 | $11 |
Year by year
| 2024 | 111 | 33 | 0% (0) | 13% | $194,846 |
| 2023 | 79 | 20 | None | 23% | $401,744 |
| 2022 | 59 | 18 | 0% (0) | 34% | $346,200 |
| 2021 | 58 | None | None | 41% | $360,930 |
| 2020 | 44 | 13 | 0% (0) | 45% | $305,096 |
| 2019 | 62 | 14 | 0% (0) | 21% | $82,786 |
| 2018 | 98 | 16 | None | 21% | $191,232 |
| 2017 | 121 | 17 | None | 31% | $356,685 |
| 2016 | 93 | 18 | 0% (0) | 38% | $379,353 |
| 2015 | 114 | 22 | 0% (0) | 44% | $514,275 |
| 2014 | 170 | 25 | None | None | $257,749 |
| 2013 | 126 | 31 | None | 17% | $23,252 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Acyclovir | 19 | $241 | $13 |
2021: 1 drug
| Imbruvica | 15 | $214,043 | $14,270 |
2020: 2 drugs
| Imbruvica | 13 | $176,521 | $13,579 |
| Entecavir | 11 | $643 | $58 |
2019: 2 drugs
| Gabapentin | 11 | $121 | $11 |
| Ondansetron | 11 | $94 | $9 |
2018: 3 drugs
| Imbruvica | 12 | $142,912 | $11,909 |
| Ondansetron | 16 | $219 | $14 |
| Prednisone | 17 | $76 | $4 |
2017: 2 drugs
| Blincyto | 13 | $189,862 | $14,605 |
| Allopurinol | 12 | $133 | $11 |
2016: 2 drugs
| Imbruvica | 33 | $367,918 | $11,149 |
| Enoxaparin | 13 | $3,781 | $291 |
2015: 2 drugs
| Imbruvica | 42 | $470,463 | $11,201 |
| Prednisone | 11 | $38 | $3 |
2014: 5 drugs
| Imbruvica | 21 | $215,756 | $10,274 |
| Ondansetron | 11 | $217 | $20 |
| Acyclovir | 12 | $210 | $18 |
| Prednisone | 32 | $117 | $4 |
| Allopurinol | 13 | $80 | $6 |
2013: 1 drug
| Prednisone | 12 | $36 | $3 |
Money from drug and device companies
$1,646 in 2025
| 2025 | 1 | 3 | $1,625 | $1,646 |
| 2024 | 1 | 7 | $9,600 | $10,184 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| BeOne Medicines USA | Brukinsa | $1,646 | 3 payments
|
See all 3 published payments
| BeOne Medicines USA | Consulting · 2025-12-02 | None | $975 |
| BeOne Medicines USA | Consulting · 2025-05-27 | None | $650 |
| BeOne Medicines USA | Meals · 2025-04-22 | Brukinsa | $21 |
See earlier years (2024)
2024: $10,184
| ADC Therapeutics America | None | $10,184 | 7 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| BeiGene, Ltd. · A Phase 2, Open-Label Study of Bgb-A317 in Patients With Relapsed Or Refractory Mature T- and Nk- Neoplasms · 2020 | This clinician | $650 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1316127657
- Licence
- CA A100890California A100890: Current · expires 2028-11-30
- Trained
- Stanford University School of Medicine, 2006
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Medical oncology (207RX0202X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-11-04
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 875 Blake Wilbur Dr, Palo Alto, CA, 94304